Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/20/2012CA2405076C Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/20/2012CA2392453C Modulation of signal transduction
03/20/2012CA2384080C Skin conditioner
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2351580C Stabilization of macrolides
03/20/2012CA2273622C Inhibition of nmda receptor signalling in reducing neuronal damage
03/20/2012CA2224320C Method of promoting hypoallergenicity or tolerogenic immune response and compositions therefor
03/16/2012CA2752131A1 Novel derivatives of dihydrobenzoxathiazepines, their preparation process and pharmaceutical compositions containing them
03/15/2012WO2012034116A2 Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
03/15/2012WO2012034095A1 Compounds and compositions as trk inhibitors
03/15/2012WO2012034091A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012WO2012034058A1 Hydrogen bond forming fluoro ketolides for treating diseases
03/15/2012WO2012034055A2 Compounds as c-met kinase inhibitors
03/15/2012WO2012034038A2 Dual inhibitors of farnesyltransferase and geranylgeranyltransferase i
03/15/2012WO2012033983A2 Candesartan pharmaceutical compositions
03/15/2012WO2012033956A1 Cognition enhancing compounds and compositions, methods of making, and methods of treating
03/15/2012WO2012033952A1 3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
03/15/2012WO2012033941A1 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012WO2012033916A1 Method for treating chronic pain
03/15/2012WO2012033878A2 Compounds and methods for acemif inhibition and the treatment of parasites
03/15/2012WO2012033874A1 Method of treating compulsive self-injurious behaviors
03/15/2012WO2012033858A2 Boron-containing small molecules
03/15/2012WO2012033846A1 Arylpropionyl-triketone antibacterial agents
03/15/2012WO2012033815A1 Arylpropionyl-alpha-pyrone antibacterial agents
03/15/2012WO2012033811A1 Compositions for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
03/15/2012WO2012033792A2 Treatment of diseases
03/15/2012WO2012033735A1 Inhibitors of human immunodeficiency virus replication
03/15/2012WO2012033720A1 Benzoic acid compounds for reducing uric acid
03/15/2012WO2012033703A1 Continuous photolytic process for the preparation of vitamin d related substances
03/15/2012WO2012033625A1 Chlorhexidine acetate antiseptic cleaning agent
03/15/2012WO2012033601A1 Thiosemicarbazones with mdr1 - inverse activity
03/15/2012WO2012033590A1 Chemically stable dispersions of prothioconazole and processes for preparing them
03/15/2012WO2012033525A2 P53-mdm2 antagonists
03/15/2012WO2012033478A1 An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
03/15/2012WO2012033435A1 Method, compound, pharmaceutical composition and drug for restoring memory lost in normal and pathological contexts
03/15/2012WO2012033390A2 Novel thiophene derivative as sglt2 inhibitor and pharmaceutical composition comprising same
03/15/2012WO2012033353A2 Sesterterpene compounds and use thereof
03/15/2012WO2012033348A2 Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol
03/15/2012WO2012033266A1 Novel artemisinin or deoxoartemisinin-glycolipid hybrid derivatives and antiangiogenic use thereof
03/15/2012WO2012033261A1 Pharmaceutical composition for preventing or treating sepsis, containing genipin or derivative thereof
03/15/2012WO2012033235A1 Pharmaceutical composition for treating anxiety disorder, containing n-acetyl-l-cysteine or derivative thereof
03/15/2012WO2012033218A1 HYDROUS CRYSTALS OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID, POWDER CONTAINING HYDROUS CRYSTALS OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID, METHOD FOR PRODUCING THE HYDROUS CRYSTALS, METHOD FOR PRODUCING THE POWDER, USE OF THE HYDROUS CRYSTALS, AND USE OF THE POWDER
03/15/2012WO2012033196A1 Foamable aerosol composition
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033189A1 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
03/15/2012WO2012033151A1 Composition for preventing inflammations
03/15/2012WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012WO2012033144A1 Pyrazoloquinoline compound
03/15/2012WO2012033101A1 Quinoxaline compound
03/15/2012WO2012033070A1 Therapeutic agent for pain
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012WO2012033016A1 Drug for treating tumor, antitumor agent, method for treating tumor and kit for treating tumor
03/15/2012WO2012032952A1 Compound having antimalarial activity and antimalarial drug
03/15/2012WO2012032545A1 Processes for preparing dronedarone and its intermediates
03/15/2012WO2012032541A1 "adefovir dipivoxil pseudopolymorph"
03/15/2012WO2012032523A2 Compositions comprising acidic extracts of mastic gum
03/15/2012WO2012032513A1 Boranophosphate derivatives for the treatment of osteoarthritis
03/15/2012WO2012032509A2 Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof
03/15/2012WO2012032479A1 L,5-diaryl-2-alkvlpvrrole-3-substituted nitro esters, selective cox-2 inhibitors and nitric oxide donors
03/15/2012WO2012032417A2 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
03/15/2012WO2012032415A2 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
03/15/2012WO2012032414A2 Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
03/15/2012WO2012032360A2 Novel use
03/15/2012WO2012032337A2 A transdermal drug administration device
03/15/2012WO2012032334A1 Quinoline and quinoxaline derivatives as kinase inhibitors
03/15/2012WO2012032304A1 Compounds
03/15/2012WO2012032185A1 Method for producing crystalline 5-aminosalicylic acid
03/15/2012WO2012032151A2 Hybrid cooperative complexes of hyaluronic acid
03/15/2012WO2012032150A2 Process for obtaining hyaluronic acid of defined molecular weight
03/15/2012WO2012032067A1 Polymorphs and salts of n- [5- [4- (5- { [(2r,6s) -2, 6 - dimethyl - 4 -morpholinyl] methyl} - 1, 3 - oxazol - 2 - yl) - 1h- inda zol-6-yl] -2- (methyloxy) - 3 - pyridinyl] methanesulfonamide
03/15/2012WO2012032065A1 Indazole derivatives for use in the treatment of influenza virus infection
03/15/2012WO2012032031A1 Substituted imidazopyridazines
03/15/2012WO2012032018A1 Heteroarylmethyl amides
03/15/2012WO2012032014A1 Ethyne derivatives, pharmaceutical compositions and uses thereof
03/15/2012WO2012031999A2 Low-dose transdermal patches with high drug release
03/15/2012WO2012031993A1 Novel n-hydroxy-benzamides for the treatment of cancer
03/15/2012WO2012031979A1 Nasal spray
03/15/2012WO2012031978A1 Laxative containing polyethylene glycol and electrolytes
03/15/2012WO2012031941A2 2-(R²-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINE FOR TREATING A β-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
03/15/2012WO2012031773A1 Sdf-1 binding nucleic acids and the use thereof in cancer treatment
03/15/2012WO2012031763A1 Use of inhibitors of phospholipase a2 for the treatment or prevention of flavivirus infection
03/15/2012WO2012031736A1 Process for the production of l-carnitine tartrate
03/15/2012WO2012031603A2 Airway administration of angiogenesis inhibitors
03/15/2012WO2012031563A1 Heterocyclic amino berbamine derivatives, preparation method and use thereof
03/15/2012WO2012031539A1 Nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments
03/15/2012WO2012031534A1 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine, preparation method and pharmaceutical use thereof
03/15/2012WO2012031466A1 2-(p-octylphenylethyl)-2-amino propanediol derivatives and uses thereof
03/15/2012WO2012031445A1 Processes for preparing piperazinium salts of kmup and use thereof
03/15/2012WO2012031383A1 Amide compounds
03/15/2012WO2012031382A1 Special nutrient supplements for pregnant women
03/15/2012WO2012031307A1 Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes
03/15/2012WO2012013990A3 Losartan potassium for treating psoriasis
03/15/2012WO2012012736A3 Method of treating a viral infection dysfunction by disrupting an adenosine receptor pathway
03/15/2012WO2012012307A9 Sulfonyl compounds which modulate the cb2 receptor
03/15/2012WO2012011129A3 Novel polymorph of bis[(e)-7-[4-(4-fluorophenyl)-6-iso-propyl-2-[methyl (methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt
03/15/2012WO2012010938A3 Pharmaceutical composition of cefditoren pivoxil
03/15/2012WO2012009699A3 Process for preparing antiviral compounds
1 ... 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 ... 7860